Comunicado de prensa

April 14, 2023 11:42 AM

Updated statement regarding LockBit claims

Mike Beck, Chief Information Security Officer, Darktrace

We have completed a thorough security investigation following yesterday’s tweets by LockBit claiming they had compromised Darktrace’s internal systems. We can confirm that there has been no compromise of our systems or any of our affiliate systems. Our service to our customers remains uninterrupted and is operating as normal and no further action is required.

Comunicado de prensa

April 13, 2023 9:30 AM

Statement regarding LockBit claims

Earlier this morning we became aware of tweets from LockBit, the cyber-criminal gang, claiming that they had compromised Darktrace’s internal security systems and had accessed our data. Our security teams have run a full review of our internal systems and can see no evidence of compromise. None of the LockBit social media posts link to any compromised Darktrace data. We will continue to monitor the situation extremely closely, but based on our current investigations we are confident that our systems remain secure and all customer data is fully protected.


Comunicado de prensa

Darktrace Antigena Named ‘Best AI Product in Security’

Autonomous Response Technology Wins Prestigious CogX AI Innovation Award
Cambridge, Reino Unido
June 21, 2017

Cobertura mediática

News publication logo

Darktrace Antigena Named ‘Best AI Product in Security’

Leer la historia
June 21, 2017

Darktrace, the leader in Enterprise Immune System technology, has today announced that its pioneering autonomous response technology Darktrace Antigena was named ‘Best AI Product in Security’ at the CogX AI Innovation Awards held in London last night.

The CogX AI Awards celebrate the most innovative contributions to the fields of AI, data science and machine learning. Darktrace Antigena’s autonomous response technology is the world’s first and only proven AI technology capable of taking precise remedial action against emerging cyber-attacks in real time.

Leveraging advances in machine learning and probabilistic mathematics, the Enterprise Immune System self-learns the normal ‘pattern of life’ for every user and device on a network and uses that constantly evolving baseline to detect attacks in their nascent stages. As a part of the Enterprise Immune System, Darktrace Antigena acts as a digital antibody, taking only very targeted remedial action against in-progress threats – for example, it can slow down or stop a compromised connection or device, but does not impact normal business operations. By replicating this function of the human immune system, Darktrace Antigena restrains or contains threats instantaneously, augmenting security teams in the face of stealthy, never-seen-before attacks.

The CogX ‘Best AI Product in Security’ award is further testament to the fundamental power of our technology,” commented Poppy Gustafsson, CEO EMEA, Darktrace. “Despite all the hype around machine learning, the reality is that it is incredibly difficult to get right in the context of complex networks and brazen attacks that spread at machine speeds. Darktrace Antigena truly delivers on the promise of AI in cyber as the only autonomous response technology proven to neutralize pernicious attacks within minutes, before they have inflicted damage.”

Acerca de Darktrace

Acerca de Darktrace

Darktrace es la empresa líder mundial en aprendizaje automático para la ciberseguridad. Creado por matemáticos de la Universidad de Cambridge, el Enterprise Immune System utiliza algoritmos de IA para detectar y actuar automáticamente contra las ciberamenazas en todo tipo de redes, incluidas las físicas, las de la nube y las virtualizadas, así como los sistemas de control industrial y de IoT. Darktrace, una plataforma autoconfigurable, no requiere ninguna configuración previa, e identifica las amenazas avanzadas en tiempo real, incluidos los días cero, los atacantes internos y los sigilosos y silenciosos. Con sede en San Francisco y Cambridge (Reino Unido), Darktrace cuenta con 23 oficinas en todo el mundo.

share this article
No se ha encontrado ningún artículo.
Contactos con los medios de comunicación
No se ha encontrado ningún artículo.